138 related articles for article (PubMed ID: 2908700)
1. Effect of propranolol on ventricular repolarization and refractoriness: role of beta-blockade versus direct membrane effects.
Euler DE; Scanlon PJ
Cardiovasc Drugs Ther; 1988 Mar; 1(6):605-12. PubMed ID: 2908700
[TBL] [Abstract][Full Text] [Related]
2. Differences in refractory-period response of canine subendocardium and subepicardium to bunazosin, an alpha1-adrenoceptor antagonist, and propranolol during myocardial ischemia.
Tanabe T; Usui K; Kusuzaki S; Yoshitake M; Takigawa O; Iwamoto T; Handa S
J Cardiovasc Pharmacol; 1997 Dec; 30(6):824-30. PubMed ID: 9436824
[TBL] [Abstract][Full Text] [Related]
3. The effects of selective stellate ganglion manipulation on ventricular refractoriness and excitability.
García-Calvo R; Chorro FJ; Sendra M; Alberola A; Sanchis J; Navarro J; Valentín V; López-Merino V; Such L
Pacing Clin Electrophysiol; 1992 Oct; 15(10 Pt 1):1492-503. PubMed ID: 1383961
[TBL] [Abstract][Full Text] [Related]
4. Disproportional response between refractory period and blood flow to alpha 1- and beta-adrenoceptor blockade in canine ischemic myocardium.
Usui K; Tanabe T; Handa S; Shinozaki Y; Mori H
Cardiovasc Drugs Ther; 1998 Dec; 12(6):561-71. PubMed ID: 10410826
[TBL] [Abstract][Full Text] [Related]
5. Changes in atrial and ventricular refractoriness and in atrioventricular nodal conduction produced by combinations of vagal and sympathetic stimulation that result in a constant spontaneous sinus cycle length.
Inoue H; Zipes DP
Circ Res; 1987 Jun; 60(6):942-51. PubMed ID: 3594761
[TBL] [Abstract][Full Text] [Related]
6. Electrophysiological effects of high-dose propranolol in dogs: evidence in vivo for effects not mediated by the beta adrenoceptor.
Dawson AK; Reele SB; Wood AJ; Duff HJ; Woosley RL; Smith RF
J Pharmacol Exp Ther; 1984 Apr; 229(1):91-7. PubMed ID: 6323694
[TBL] [Abstract][Full Text] [Related]
7. Vasoactive intestinal polypeptide facilitates atrioventricular nodal conduction and shortens atrial and ventricular refractory periods in conscious and anesthetized dogs.
Rigel DF; Lathrop DA
Circ Res; 1990 Dec; 67(6):1323-33. PubMed ID: 2245498
[TBL] [Abstract][Full Text] [Related]
8. Differential sensitivity of sinus node, atrioventricular node, atrium, and ventricle to propranolol.
Chang MS; Zipes DP
Am Heart J; 1988 Aug; 116(2 Pt 1):371-8. PubMed ID: 3400563
[TBL] [Abstract][Full Text] [Related]
9. Prolonged ventricular refractoriness and action potential duration after beta-adrenoreceptor blockade in the dog heart in situ.
Amlie JP; Refsum H; Landmark KH
J Cardiovasc Pharmacol; 1982; 4(1):157-62. PubMed ID: 6176793
[TBL] [Abstract][Full Text] [Related]
10. Effects of concentration and steric configuration of propranolol on AV conduction and ventricular repolarization in the dog.
Brorson L; Reele S; Dupont W; Woosley R; Shand D; Smith R
J Cardiovasc Pharmacol; 1981; 3(4):692-703. PubMed ID: 6167800
[TBL] [Abstract][Full Text] [Related]
11. Effects of intravenous propranolol on human ventricular strength interval curves.
Kadish AH; Goldberger JJ; Shah A; Johnson D
J Investig Med; 1998 Jun; 46(5):210-6. PubMed ID: 9676053
[TBL] [Abstract][Full Text] [Related]
12. Ventricular monophasic action potential changes associated with neurogenic T wave abnormalities and isoproterenol administration in dogs.
Kuo CS; Surawicz B
Am J Cardiol; 1976 Aug; 38(2):170-7. PubMed ID: 952261
[TBL] [Abstract][Full Text] [Related]
13. Sodium channel block produces opposite electrophysiological effects in canine ventricular epicardium and endocardium.
Krishnan SC; Antzelevitch C
Circ Res; 1991 Aug; 69(2):277-91. PubMed ID: 1650294
[TBL] [Abstract][Full Text] [Related]
14. Effects of the beta-adrenergic blocking agents propranolol and timolol on canine cardiac refractory periods.
Jaillon P; Weissenburger J; Heckle J; Cheymol G
Eur J Pharmacol; 1979 Oct; 58(3):265-71. PubMed ID: 510358
[TBL] [Abstract][Full Text] [Related]
15. Results of sympathetic denervation in the canine heart: supersensitivity that may be arrhythmogenic.
Inoue H; Zipes DP
Circulation; 1987 Apr; 75(4):877-87. PubMed ID: 3829345
[TBL] [Abstract][Full Text] [Related]
16. Class III action of beta-blocking agents.
Taggart P; Donaldson R; Abed J; Nashat F
Cardiovasc Res; 1984 Nov; 18(11):683-9. PubMed ID: 6149809
[TBL] [Abstract][Full Text] [Related]
17. Effects of propranolol on ventricular repolarization in man.
Endresen K; Amlie JP
Eur J Clin Pharmacol; 1990; 39(2):123-5. PubMed ID: 2253660
[TBL] [Abstract][Full Text] [Related]
18. Ventricular electrophysiology of quinidine-propranolol combinations in the dog heart.
Korte DW; Nash CB
J Pharmacol Exp Ther; 1976 May; 197(2):452-7. PubMed ID: 1271287
[TBL] [Abstract][Full Text] [Related]
19. Cardiac electrophysiologic properties of dl-propranolol, d-propranolol, l-propranolol and dl-pindolol in anesthetized dogs.
Jaillon P; Hecklé J; Weissenburger J; Cheymol G
J Pharmacol Exp Ther; 1980 Feb; 212(2):347-53. PubMed ID: 6101348
[No Abstract] [Full Text] [Related]
20. Membrane stabilizing activity and beta-adrenoceptor antagonist-induced bradycardia in conscious dogs.
Boucher M; Chapuy E; Duchêne-Marullaz P
Eur J Pharmacol; 1992 Feb; 211(3):343-9. PubMed ID: 1352254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
